Fact CheckerSign in

NCT06974240Completed

Social Robotics for Autism

Social Robotics Intervention for Improving Socio-Pragmatic Skills in Autism: A Randomized Controlled Trial

Source: ClinicalTrials.gov · Last updated 15 May 2025

Brief summary (registry, in English)

Socio-pragmatics focuses on the study of language in the context of social interactions. It explores how individuals use language to communicate effectively in specific social situations, taking into consideration the social, cultural and contextual factors that influence communication. Socio-pragmatics analyzes linguistic and nonlinguistic behaviors, such as gestures, facial expressions, tone of voice, and posture, to understand intended meaning, social implications, and shared communicative norms. Children with autism often present difficulties in social-pragmatic skills. The integration of advanced technologies can play a crucial role in innovative approaches to the development of this skill. In this experimental protocol, an attempt will be made to demonstrate the effectiveness of training through the use of social robots by comparing the performance of an ASD group performing a treatment using social robots with a control group performing the same in a traditional manner.

Status (registry)
Completed
Study type
Interventional
Enrollment
20 (actual)
First submitted
24 Apr 2025
Start date
20 Jan 2024
Primary completion date
30 Oct 2024
Lead sponsor
Istituto per la Ricerca e l'Innovazione Biomedica
Diseases
Autism
NCT number
NCT06974240

What you commit to

  • Study type: Interventional
  • Participants enrolled: 20
  • From 20 Jan 2024 to the primary completion date, 30 Oct 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Current use of psychotropic medications

Other

  • Absence of a clinical diagnosis of ASD based on DSM-5 criteria
  • Verbal or performance IQ ≤ 75, or total IQ ≤ 85 as assessed by WISC-IV
  • Presence of aggressive behavior or severe oppositional tendencies
  • Hearing, vision, or physical impairments that could hinder participation in the intervention

Who the study is looking for

  • Aged between 8 and 13 years
  • Clinical diagnosis of ASD according to DSM-5 criteria by a licensed child neuropsychiatrist
  • Verbal and performance IQ \> 75 and total IQ \> 85, assessed with the WISC-IV
  • No current aggressive behavior or severe oppositional tendencies
  • No hearing, vision, or physical impairments that could interfere with participation
  • Not currently taking any psychotropic medications

Age in the registry: 8 years to 13 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Italy Institute for Biomedical Research and Innovation (IRIB) - National Research Council (CNR)
Coordinator of this site? Confirm its status
MessinaItalyUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.